Home
>
National Drug Code (NDC)
>
Revlimid
Revlimid - 59572-420-21 - (Lenalidomide)
Drug Information of Revlimid
| Product NDC: | 59572-420 |
| Proprietary Name: | Revlimid |
| Non Proprietary Name: | Lenalidomide |
| Active Ingredient(s): | 20 mg/1 & nbsp; Lenalidomide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Revlimid
| Product NDC: | 59572-420 |
| Labeler Name: | Celgene Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021880 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130606 |
Package Information of Revlimid
| Package NDC: | 59572-420-21 |
| Package Description: | 21 CAPSULE in 1 BOTTLE (59572-420-21) |
NDC Information of Revlimid
| NDC Code | 59572-420-21 |
| Proprietary Name | Revlimid |
| Package Description | 21 CAPSULE in 1 BOTTLE (59572-420-21) |
| Product NDC | 59572-420 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lenalidomide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20130606 |
| Marketing Category Name | NDA |
| Labeler Name | Celgene Corporation |
| Substance Name | LENALIDOMIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
